Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[Ikaros (IKZF1) alterations and minimal residual disease at day 15 assessed by flow cytometry predict prognosis of childhood BCR/ABL-negative acute lymphoblastic leukemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• assertion description "[Ikaros (IKZF1) alterations and minimal residual disease at day 15 assessed by flow cytometry predict prognosis of childhood BCR/ABL-negative acute lymphoblastic leukemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Ikaros (IKZF1) alterations and minimal residual disease at day 15 assessed by flow cytometry predict prognosis of childhood BCR/ABL-negative acute lymphoblastic leukemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Ikaros (IKZF1) alterations and minimal residual disease at day 15 assessed by flow cytometry predict prognosis of childhood BCR/ABL-negative acute lymphoblastic leukemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP420326.RASMzXU4kYg9KQETCoCi6We2OTX9eHXerPooALsDGVeOA130_assertion description "[Ikaros (IKZF1) alterations and minimal residual disease at day 15 assessed by flow cytometry predict prognosis of childhood BCR/ABL-negative acute lymphoblastic leukemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP420326.RASMzXU4kYg9KQETCoCi6We2OTX9eHXerPooALsDGVeOA130_provenance.
• NP219139.RA8FuCXYSXuHj4i-a_z_NWF3dauJYcxCSZlxc2n3hS_Qk130_assertion description "[Ikaros (IKZF1) alterations and minimal residual disease at day 15 assessed by flow cytometry predict prognosis of childhood BCR/ABL-negative acute lymphoblastic leukemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP219139.RA8FuCXYSXuHj4i-a_z_NWF3dauJYcxCSZlxc2n3hS_Qk130_provenance.
• NP219380.RA-_9v_AgD3A9mSuO6-Wc-qmDqgkEPgH9H4ew6dGKE6-g130_assertion description "[Ikaros (IKZF1) alterations and minimal residual disease at day 15 assessed by flow cytometry predict prognosis of childhood BCR/ABL-negative acute lymphoblastic leukemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP219380.RA-_9v_AgD3A9mSuO6-Wc-qmDqgkEPgH9H4ew6dGKE6-g130_provenance.
• NP840606.RAwDY_n1XFs3A1CctU4daIVOx2ClBrcqyDY8GfTdIXrHo130_assertion description "[Ikaros (IKZF1) alterations and minimal residual disease at day 15 assessed by flow cytometry predict prognosis of childhood BCR/ABL-negative acute lymphoblastic leukemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP840606.RAwDY_n1XFs3A1CctU4daIVOx2ClBrcqyDY8GfTdIXrHo130_provenance.
• NP840646.RA3yDfjM61XPfN4b9Yj-06eo1o9vwg0OiBzcK0P3F7_lM130_assertion description "[Ikaros (IKZF1) alterations and minimal residual disease at day 15 assessed by flow cytometry predict prognosis of childhood BCR/ABL-negative acute lymphoblastic leukemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP840646.RA3yDfjM61XPfN4b9Yj-06eo1o9vwg0OiBzcK0P3F7_lM130_provenance.
• NP1014772.RA6Z5VQjo1g1cE0F46shOujpNO14q_nlN-dzR3vMs_mw8130_assertion description "[Ikaros (IKZF1) alterations and minimal residual disease at day 15 assessed by flow cytometry predict prognosis of childhood BCR/ABL-negative acute lymphoblastic leukemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1014772.RA6Z5VQjo1g1cE0F46shOujpNO14q_nlN-dzR3vMs_mw8130_provenance.
• NP219663.RAMhJXkgMWF4deQ-fqqW4KtKhC27VLzXHzB3k2tMezaBI130_assertion description "[Ikaros (IKZF1) alterations and minimal residual disease at day 15 assessed by flow cytometry predict prognosis of childhood BCR/ABL-negative acute lymphoblastic leukemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP219663.RAMhJXkgMWF4deQ-fqqW4KtKhC27VLzXHzB3k2tMezaBI130_provenance.
• NP1014778.RAakWO59KLzzyhdbDSJ0j0cdXJIsvo18hD5L_mJ9iP0ms130_assertion description "[Ikaros (IKZF1) alterations and minimal residual disease at day 15 assessed by flow cytometry predict prognosis of childhood BCR/ABL-negative acute lymphoblastic leukemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1014778.RAakWO59KLzzyhdbDSJ0j0cdXJIsvo18hD5L_mJ9iP0ms130_provenance.
• assertion description "[Ikaros (IKZF1) alterations and minimal residual disease at day 15 assessed by flow cytometry predict prognosis of childhood BCR/ABL-negative acute lymphoblastic leukemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Ikaros (IKZF1) alterations and minimal residual disease at day 15 assessed by flow cytometry predict prognosis of childhood BCR/ABL-negative acute lymphoblastic leukemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Ikaros (IKZF1) alterations and minimal residual disease at day 15 assessed by flow cytometry predict prognosis of childhood BCR/ABL-negative acute lymphoblastic leukemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP840696.RAu5cM7dF8vToHx-AJSTj_laaH2y-jYBHvcaiCkHp5-Gc130_assertion description "[Ikaros (IKZF1) alterations and minimal residual disease at day 15 assessed by flow cytometry predict prognosis of childhood BCR/ABL-negative acute lymphoblastic leukemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP840696.RAu5cM7dF8vToHx-AJSTj_laaH2y-jYBHvcaiCkHp5-Gc130_provenance.
• NP1014775.RAIf7q_nf5E8b2MUYQU66nEXsTSs9o-VA02zIxjgM-cok130_assertion description "[Ikaros (IKZF1) alterations and minimal residual disease at day 15 assessed by flow cytometry predict prognosis of childhood BCR/ABL-negative acute lymphoblastic leukemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1014775.RAIf7q_nf5E8b2MUYQU66nEXsTSs9o-VA02zIxjgM-cok130_provenance.
• NP1014771.RAhpggv2BDjG__JC8DxGXJwvPE8u_ET9aUl2rg-gfRovM130_assertion description "[Ikaros (IKZF1) alterations and minimal residual disease at day 15 assessed by flow cytometry predict prognosis of childhood BCR/ABL-negative acute lymphoblastic leukemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1014771.RAhpggv2BDjG__JC8DxGXJwvPE8u_ET9aUl2rg-gfRovM130_provenance.
• NP1014776.RAmcBzvJsEFwgq5D8aQU8CJqnZo63i3OZfZpFBIkBKM_E130_assertion description "[Ikaros (IKZF1) alterations and minimal residual disease at day 15 assessed by flow cytometry predict prognosis of childhood BCR/ABL-negative acute lymphoblastic leukemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1014776.RAmcBzvJsEFwgq5D8aQU8CJqnZo63i3OZfZpFBIkBKM_E130_provenance.
• NP1014777.RAiV78ZPPVlwXd7i2BfqT3k2z1xerfkEwRtMKYXildz7k130_assertion description "[Ikaros (IKZF1) alterations and minimal residual disease at day 15 assessed by flow cytometry predict prognosis of childhood BCR/ABL-negative acute lymphoblastic leukemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1014777.RAiV78ZPPVlwXd7i2BfqT3k2z1xerfkEwRtMKYXildz7k130_provenance.